Vivo Bio Tech Limited
VIVOBIOT.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$330.2M
Close$
Share Statistics
| Market cap | $330.20 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.82 |
| Beta | 1.22 |
| Outstanding Shares | 22,190,600 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -10.44 |
|---|---|
| PEG | 12.14 |
| Price to Sales | 0.57 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Vivo Bio Tech Limited
247 employees
CEO: Alangudi Sankaranarayanan Vivo Bio Tech Ltd. specializes in delivering comprehensive services for pharmaceutical research and development. The company's diverse offerings encompass both in-vivo and in-vitro toxicology assessments, in-depth pharmacological investi...